CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.

von Euw E, Chodon T, Attar N, Jalil J, Koya RC, Comin-Anduix B, Ribas A. CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J Transl Med. 2009 May 20; 7:35.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens, CD
Autoimmunity
CTLA-4 Antigen
Enzyme-Linked Immunosorbent Assay
Female
Humans
Interleukin-17
Intracellular Space
Lymphocyte Activation
Male
Melanoma
Middle Aged
Neoplasm Metastasis
T-Lymphocytes, Helper-Inducer

authors with profiles

Thinle Chodon
Richard Koya